Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 247.96 CNY -1.22% Market Closed
Market Cap: 149.6B CNY
Have any thoughts about
Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock under the Base Case scenario is 171.77 CNY. Compared to the current market price of 247.96 CNY, Zhangzhou Pientzehuang Pharmaceutical Co Ltd is Overvalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
171.77 CNY
Overvaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
71
vs Industry
12
Median 3Y
18.5
Median 5Y
18.9
Industry
2.6
Forward
13.1
vs History
76
vs Industry
9
Median 3Y
64.3
Median 5Y
67.2
Industry
23
Forward
46.9
vs History
23
vs Industry
5
Median 3Y
61.1
Median 5Y
58.3
Industry
17.8
vs History
30
vs Industry
9
Median 3Y
62.2
Median 5Y
59.3
Industry
25.4
vs History
73
vs Industry
7
Median 3Y
14.2
Median 5Y
14.8
Industry
2.2
vs History
71
vs Industry
12
Median 3Y
18.1
Median 5Y
18.7
Industry
2.8
Forward
12.5
vs History
71
vs Industry
7
Median 3Y
40
Median 5Y
40.6
Industry
5.4
vs History
79
vs Industry
9
Median 3Y
55.3
Median 5Y
57.5
Industry
13.7
Forward
36.8
vs History
79
vs Industry
11
Median 3Y
55.3
Median 5Y
57.5
Industry
17.2
Forward
37.8
vs History
25
vs Industry
7
Median 3Y
57.7
Median 5Y
55.3
Industry
16.5
vs History
28
vs Industry
6
Median 3Y
61.1
Median 5Y
58.5
Industry
19.3
vs History
63
vs Industry
6
Median 3Y
21
Median 5Y
21.9
Industry
2

Multiples Across Competitors

Competitors Multiples
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
149.6B CNY 14 50.2 41.2 41.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
367.6B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6

See Also

Discover More
Back to Top